CZ20011832A3 - Nový farmaceutický přípravek a způsob jeho přípravy - Google Patents

Nový farmaceutický přípravek a způsob jeho přípravy

Info

Publication number
CZ20011832A3
CZ20011832A3 CZ20011832A CZ20011832A CZ20011832A3 CZ 20011832 A3 CZ20011832 A3 CZ 20011832A3 CZ 20011832 A CZ20011832 A CZ 20011832A CZ 20011832 A CZ20011832 A CZ 20011832A CZ 20011832 A3 CZ20011832 A3 CZ 20011832A3
Authority
CZ
Czechia
Prior art keywords
preparing
pharmaceutical preparation
novel pharmaceutical
methyl
thiadiazolidine
Prior art date
Application number
CZ20011832A
Other languages
English (en)
Other versions
CZ300543B6 (cs
Inventor
Helle Weibel
Thyge Borup Hjorth
Original Assignee
Novo Nordisk A/S
Dr. Reddy´S Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk A/S, Dr. Reddy´S Research Foundation filed Critical Novo Nordisk A/S
Publication of CZ20011832A3 publication Critical patent/CZ20011832A3/cs
Publication of CZ300543B6 publication Critical patent/CZ300543B6/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ20011832A 1998-12-01 1999-11-29 Farmaceutický prípravek a zpusob jeho prípravy CZ300543B6 (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA199801580 1998-12-01

Publications (2)

Publication Number Publication Date
CZ20011832A3 true CZ20011832A3 (cs) 2001-10-17
CZ300543B6 CZ300543B6 (cs) 2009-06-10

Family

ID=8106261

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20011832A CZ300543B6 (cs) 1998-12-01 1999-11-29 Farmaceutický prípravek a zpusob jeho prípravy

Country Status (21)

Country Link
US (1) US7439248B1 (cs)
EP (1) EP1135127B1 (cs)
JP (2) JP5524435B2 (cs)
KR (1) KR100690311B1 (cs)
CN (1) CN1158075C (cs)
AT (1) ATE316376T1 (cs)
AU (1) AU776299B2 (cs)
BR (1) BR9915835A (cs)
CA (1) CA2352430C (cs)
CZ (1) CZ300543B6 (cs)
DE (1) DE69929635T2 (cs)
ES (1) ES2257886T3 (cs)
HU (1) HUP0104544A3 (cs)
IL (3) IL143299A0 (cs)
NO (1) NO329909B1 (cs)
PL (1) PL197077B1 (cs)
RU (1) RU2233659C2 (cs)
TW (1) TWI235657B (cs)
UA (1) UA75569C2 (cs)
WO (1) WO2000032191A1 (cs)
ZA (1) ZA200104261B (cs)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU776299B2 (en) * 1998-12-01 2004-09-02 Dr Reddy's Laboratories, Inc. New pharmaceutical composition and the process for its preparation
US20010047032A1 (en) * 1999-12-30 2001-11-29 Castillo Gerardo M. Polyhydroxylated aromatic compounds for the treatment of amyloidosis and alpha-synuclein fibril diseases
EP1303273A1 (en) * 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
AU2000249111A1 (en) * 2000-05-30 2001-12-11 Dr. Reddy's Research Foundation New pharmaceutical composition and the process for its preparation
AU2002366313A1 (en) * 2001-12-19 2003-06-30 Takeda Chemical Industries, Ltd. Solid compositions containng compounds unstable to oxygen and method for stabilization thereof
WO2006002255A2 (en) * 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. A pharmaceutical formulation of balaglitazone
CL2008000596A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 1-(6-[(3-ciclobutil-2,3,4,5-tetrahidro-1h-3-benzazepin-7-il)oxi]-3-piridinil)-2-pirrolidinona, un estabilizador, un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4280997A (en) * 1978-12-08 1981-07-28 Johannes Van Leverink Extrusion process for the preparation of anhydrous stable lactose
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
CA2019324C (en) * 1989-07-10 1996-08-20 Robert L. Jerzewski Fosinopril tablet formulations
IT1238072B (it) * 1990-01-19 1993-07-03 Sclavo Spa Composizioni farmaceutiche e forme di dosaggio per la somministrazione orale di calcitonina
JPH06505498A (ja) * 1991-04-04 1994-06-23 ザ、プロクター、エンド、ギャンブル、カンパニー 咀嚼性制酸組成物
CZ227093A3 (en) * 1991-04-29 1994-03-16 Merck & Co Inc Mixture suitable for the preparation of tablets by direct moulding
TW268952B (cs) * 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
ATE227122T1 (de) * 1993-09-03 2002-11-15 Smithkline Beecham Corp Stabilisierte tablettenformulierung
US5532256A (en) 1994-05-18 1996-07-02 American Home Products Corporation New azolidinediones and thiadiazolidinediones as antihyperglycemic agents
ES2079327B1 (es) * 1994-12-13 1996-08-01 Lilly Sa Formulaciones farmaceuticas de cefaclor.
WO1996018386A1 (en) * 1994-12-14 1996-06-20 Enbalt Trading Limited Pharmaceutical tablet formulations for direct compression
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
JPH09249561A (ja) * 1996-03-15 1997-09-22 Teikoku Chem Ind Corp Ltd 医薬組成物
HU222109B1 (hu) * 1996-09-10 2003-04-28 EGIS Gyógyszergyár Rt. Captopriltartalmú tabletták és eljárás ezek előállítására
ES2199366T3 (es) * 1996-12-31 2004-02-16 Dr. Reddy's Laboratories Ltd. Compuestos heterociclicos, procedimiento para su preparacion y composiciones farmaceuticas que los contienen y su uso en el tratamiento de diabetes y enfermedades relacionadas.
DE69824756T2 (de) 1997-12-02 2005-07-14 Dr. Reddy's Laboratories Ltd. Substituierte thiazolidinedione und oxazolidinedione mit antidiabetischen,hypolipidämischen und antihypertensiven eigenschaften
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
AU776299B2 (en) * 1998-12-01 2004-09-02 Dr Reddy's Laboratories, Inc. New pharmaceutical composition and the process for its preparation
EP1303273A1 (en) * 2000-05-26 2003-04-23 Novo Nordisk A/S New pharmaceutical composition and the process for its preparation
WO2006002255A2 (en) 2004-06-23 2006-01-05 Dr. Reddy's Laboratories Ltd. A pharmaceutical formulation of balaglitazone

Also Published As

Publication number Publication date
IL179865A0 (en) 2007-05-15
JP2002531404A (ja) 2002-09-24
KR100690311B1 (ko) 2007-03-09
CN1356901A (zh) 2002-07-03
NO20012673L (no) 2001-05-31
PL348601A1 (en) 2002-06-03
UA75569C2 (en) 2006-05-15
HUP0104544A2 (en) 2002-08-28
EP1135127A1 (en) 2001-09-26
JP2012144560A (ja) 2012-08-02
AU776299B2 (en) 2004-09-02
NO20012673D0 (no) 2001-05-31
CN1158075C (zh) 2004-07-21
ZA200104261B (en) 2002-05-24
CA2352430A1 (en) 2000-06-08
RU2233659C2 (ru) 2004-08-10
CA2352430C (en) 2008-11-18
US7439248B1 (en) 2008-10-21
EP1135127B1 (en) 2006-01-25
ES2257886T3 (es) 2006-08-01
CZ300543B6 (cs) 2009-06-10
TWI235657B (en) 2005-07-11
JP5524435B2 (ja) 2014-06-18
BR9915835A (pt) 2001-08-21
DE69929635D1 (de) 2006-04-13
ATE316376T1 (de) 2006-02-15
HUP0104544A3 (en) 2003-12-29
PL197077B1 (pl) 2008-02-29
KR20010099827A (ko) 2001-11-09
WO2000032191A1 (en) 2000-06-08
AU1376200A (en) 2000-06-19
IL179865A (en) 2009-12-24
NO329909B1 (no) 2011-01-24
IL143299A (en) 2006-12-31
IL143299A0 (en) 2002-04-21
DE69929635T2 (de) 2006-09-21

Similar Documents

Publication Publication Date Title
HUP0203841A3 (en) 5-membered heteroaromatic compounds and use thereof for preparation of pharmaceutical compositions, and pharmaceutical compositions containing them
WO2000017190A3 (fr) Derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
HUP0203902A3 (en) Substituted oxazolidinones, process for their preparation and pharmaceutical compositions containing them and their use
WO2001032632A3 (en) Pharmaceutically active 4-substituted pyrimidine derivatives
HUP0303391A3 (en) Aliphatic nitrogenous five-membered ring compounds, process for their preparation, pharmaceutical compositions containing them and their use
WO2000057900A3 (en) Factor for regulation of neurite growth
HUP0203183A3 (en) Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
HUP0204226A3 (en) Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
AU2001237526A1 (en) Pharmaceutical compositions containing 3-amino-azetidine derivatives, novel derivatives and preparation thereof
HUP0204413A3 (en) Quinazoline compounds, their preparation, their use and pharmaceutical compositions containing them
HUP0201832A3 (en) Quinazoline derivatives, pharmaceutical compositions containing these compounds, and processes for preparing them
DZ3311A1 (fr) Compositions pharmaceutiques contenant des derives de 3-amino-azetidine, les nouveaux derives et leur preparation
HK1067626A1 (en) Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient
AU4949800A (en) 2-arylpurine-9-acetamide derivatives, process for the preparation thereof, medicinal compositions containing the same and intermediates of the derivatives
IL156662A0 (en) Oxazolidinone derivatives, process for the preparation thereof and pharmaceutical compositions containing the same
HK1048986A1 (en) 2'-Substituted 1,1'-iphenyl-2-carbonamides, methodfor the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds.
HUP0400832A3 (en) New amidoalkyl-piperidine and amidoalkyl-piperazine derivatives, and pharmaceutical compositions containing such derivatives as active ingredients
HUP0203597A3 (en) Pharmaceutical compositions containing zolmitriptan, process for their preparation and their use
HUP0203385A3 (en) Pyrimidine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
AU2001228811A1 (en) Nitrogen-containing 5-membered cyclic compounds and drugs containing these compounds as the active ingredient
IL179865A0 (en) Pharmaceutical composition comprising 5 - [[4-[3 - methyl- 4- oxo - 3,4 - dihydro - 2 - quinazolinyl]methoxy] phenyl-methyl]thiadiazolidine-2,4- dione in the form of a tablet a powder or a capsule and the process for its preparation
HUP0200281A2 (en) Heterocyclic benzenesulphonamide compounds as bradykinine antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0202520A3 (en) Substituted benzylthiazolidine-2,4-dione derivatives and pharmaceutical compositions containing them
PL356911A1 (en) Novel heterocyclic derivatives, preparation method and pharmaceutical compositions containing same
ZA200201521B (en) Alkoxy substituted benzimidazole compounds, pharmaceutical preparation containing the same, and methods of using the same.

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of fee

Effective date: 20141129